Q3 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NSTG | Buy | Nanostring Technologies Inc. | $71,962,000 | +32.9% | 4,036,025 | +1.9% | 16.91% | -12.2% |
| GRTS | New | Gritstone Oncology Inc | $36,560,000 | – | 2,567,445 | – | 8.59% | – |
| ETTX | New | Entasis Therapeutics Holdings Inc | $17,663,000 | – | 1,623,405 | – | 4.15% | – |
Q2 2018
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AVRO | New | AvroBio Inc. | $84,604,000 | – | 2,962,325 | – | 30.09% | – |
| FTSV | New | Forty Seven Inc | $61,071,000 | – | 3,816,951 | – | 21.72% | – |
| NSTG | New | Nanostring Technologies Inc. | $54,165,000 | – | 3,959,440 | – | 19.26% | – |
| SIEN | New | Sientra Inc. | $53,277,000 | – | 2,730,765 | – | 18.95% | – |
| HAIR | New | Restoration Robotics Inc. | $12,387,000 | – | 3,569,986 | – | 4.41% | – |
| VBIV | New | VBI Vaccines Inc. | $7,400,000 | – | 2,691,042 | – | 2.63% | – |
| EPIX | New | ESSA Pharma Inc. | $6,323,000 | – | 1,668,560 | – | 2.25% | – |
| CATB | New | Catabasis Pharmaceuticals Inc. | $1,925,000 | – | 2,008,192 | – | 0.68% | – |
Q4 2017
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | ESSA Pharma Inc. | $0 | – | -2,121,212 | – | -0.50% | – | |
| CATB | Exit | Catabasis Pharmaceuticals Inc. | $0 | – | -2,752,488 | – | -4.75% | – |
| VBIV | Exit | VBI Vaccines Inc. | $0 | – | -2,691,042 | – | -8.43% | – |
| SIEN | Exit | Sientra Inc. | $0 | – | -2,730,765 | – | -34.23% | – |
| NSTG | Exit | Nanostring Technologies Inc. | $0 | – | -3,959,440 | – | -52.08% | – |
Q2 2017
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NSTG | New | Nanostring Technologies Inc. | $65,489,000 | – | 3,959,440 | – | 60.20% | – |
| SIEN | New | Sientra Inc. | $26,543,000 | – | 2,730,765 | – | 24.40% | – |
| VBIV | New | VBI Vaccines Inc. | $11,706,000 | – | 2,691,042 | – | 10.76% | – |
| CATB | New | Catabasis Pharmaceuticals Inc. | $3,881,000 | – | 2,752,488 | – | 3.57% | – |
| New | ESSA Pharma Inc. | $1,167,000 | – | 2,121,212 | – | 1.07% | – |
Q4 2016
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | ESSA Pharma Inc. | $0 | – | -2,121,212 | – | -3.58% | – | |
| VBIV | Exit | VBI Vaccines Inc. | $0 | – | -2,691,042 | – | -5.67% | – |
| CATB | Exit | Catabasis Pharmaceuticals Inc. | $0 | – | -2,752,488 | – | -10.42% | – |
| SIEN | Exit | Sientra Inc. | $0 | – | -2,730,765 | – | -15.09% | – |
| OXFD | Exit | Oxford Immunotec Global PLC | $0 | – | -2,153,092 | – | -16.62% | – |
| NSTG | Exit | Nanostring Technologies Inc. | $0 | – | -3,959,440 | – | -48.62% | – |
Q2 2016
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NSTG | New | Nanostring Technologies Inc. | $49,889,000 | – | 3,959,440 | – | 43.64% | – |
| OXFD | New | Oxford Immunotec Global PLC | $19,378,000 | – | 2,153,092 | – | 16.95% | – |
| SIEN | New | Sientra Inc. | $17,968,000 | – | 2,730,765 | – | 15.72% | – |
| VBIV | New | VBI Vaccines Inc. | $10,630,000 | – | 2,691,042 | – | 9.30% | – |
| CATB | New | Catabasis Pharmaceuticals Inc. | $10,184,000 | – | 2,752,488 | – | 8.91% | – |
| New | ESSA Pharma Inc. | $6,257,000 | – | 2,121,212 | – | 5.47% | – |
Q4 2015
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AERI | Exit | Aerie Pharmaceuticals Inc. | $0 | – | -63,017 | – | -0.64% | – |
| TLOG | Exit | TetraLogic Pharmaceuticals Corporation | $0 | – | -4,644,705 | – | -4.94% | – |
| NEOT | Exit | Neothetics, Inc. | $0 | – | -1,071,429 | – | -4.97% | – |
| VBIV | Exit | VBI Vaccines Inc. | $0 | – | -4,971,091 | – | -7.55% | – |
| CATB | Exit | Catabasis Pharmaceuticals Inc. | $0 | – | -2,752,488 | – | -12.81% | – |
| SIEN | Exit | Sientra Inc. | $0 | – | -2,730,765 | – | -15.94% | – |
| OXFD | Exit | Oxford Immunotec Global PLC | $0 | – | -2,153,092 | – | -16.72% | – |
| NSTG | Exit | Nanostring Technologies Inc. | $0 | – | -3,959,440 | – | -36.43% | – |
Q3 2015
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OXFD | Sell | Oxford Immunotec Global PLC | $29,067,000 | -3.2% | 2,153,092 | -0.7% | 16.72% | +26.6% |
| AERI | New | Aerie Pharmaceuticals Inc. | $1,118,000 | – | 63,017 | – | 0.64% | – |
Q2 2015
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SIEN | New | Sientra Inc. | $68,897,000 | – | 2,730,765 | – | 30.30% | – |
| NSTG | New | Nanostring Technologies Inc. | $61,055,000 | – | 3,959,440 | – | 26.85% | – |
| CATB | New | Catabasis Pharmaceuticals Inc | $33,608,000 | – | 2,752,488 | – | 14.78% | – |
| OXFD | New | Oxford Immunotec Global PLC | $30,018,000 | – | 2,167,377 | – | 13.20% | – |
| VBIV | New | VBI Vaccines Inc. | $13,323,000 | – | 4,971,091 | – | 5.86% | – |
| TLOG | New | TetraLogic Pharmaceuticals Corporation | $10,867,000 | – | 4,644,705 | – | 4.78% | – |
| NEOT | New | Neothetics, Inc. | $9,643,000 | – | 1,071,429 | – | 4.24% | – |
Q4 2014
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VBIV | Exit | VBI Vaccines Inc | $0 | – | -4,971,091 | – | -6.51% | – |
| TLOG | Exit | TetraLogic Pharmaceuticals Corporation | $0 | – | -4,644,705 | – | -7.71% | – |
| OXFD | Exit | Oxford Immunotec Global PLC | $0 | – | -2,579,062 | – | -15.71% | – |
| NSTG | Exit | Nanostring Technologies Inc. | $0 | – | -3,959,440 | – | -17.28% | – |
| OPHT | Exit | Ophthotech Corp | $0 | – | -1,554,744 | – | -24.15% | – |
| AERI | Exit | Aerie Pharmaceuticals Inc. | $0 | – | -3,468,495 | – | -28.64% | – |
Q3 2014
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VBIV | New | VBI Vaccines Inc | $16,305,000 | – | 4,971,091 | – | 6.51% | – |
Q2 2014
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AERI | New | Aerie Pharmaceuticals Inc. | $85,915,000 | – | 3,468,495 | – | 30.50% | – |
| OPHT | New | Ophthotech Corp | $65,781,000 | – | 1,554,744 | – | 23.36% | – |
| NSTG | New | Nanostring Technologies Inc. | $59,194,000 | – | 3,959,440 | – | 21.02% | – |
| OXFD | New | Oxford Immunotec Global PLC | $43,406,000 | – | 2,579,062 | – | 15.41% | – |
| TLOG | New | TetraLogic Pharmaceuticals Corporation | $27,357,000 | – | 4,644,705 | – | 9.71% | – |